Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
Phase I trial design: are new methodologies being put into practice?
S F Dent, E A Eisenhauer
Current Oncology (Toronto, Ont.)
|
October 27, 2010
Endocrine therapy for male breast cancer: rates of toxicity and adherence
H Visram, F Kanji, S F Dent
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG)
S F Dent, D Klaassen, J L Pater, et al.
Current Oncology (Toronto, Ont.)
|
August 10, 2012
Use and delivery of granulocyte colony-stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy-single-centre experience
X Zhu, N Bouganim, L Vandermeer, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
O C Freedman, G G Fletcher, S Gandhi, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Optimal systemic therapy for early breast cancer in women: a clinical practice guideline
A Eisen, G G Fletcher, S Gandhi, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
S Gandhi, G G Fletcher, A Eisen, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
M Mates, G G Fletcher, O C Freedman, et al.
Current Oncology (Toronto, Ont.)
|
June 10, 2011
Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres
Y Madarnas, S F Dent, S F Husain, et al.
Investigational New Drugs
|
September 28, 2013
NCIC CTG IND.181: phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies
S F Dent, K A Gelmon, K N Chi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
Phase I trial design: are new methodologies being put into practice?
S F Dent, E A Eisenhauer
Current Oncology (Toronto, Ont.)
|
October 27, 2010
Endocrine therapy for male breast cancer: rates of toxicity and adherence
H Visram, F Kanji, S F Dent
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG)
S F Dent, D Klaassen, J L Pater, et al.
Current Oncology (Toronto, Ont.)
|
August 10, 2012
Use and delivery of granulocyte colony-stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy-single-centre experience
X Zhu, N Bouganim, L Vandermeer, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
O C Freedman, G G Fletcher, S Gandhi, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Optimal systemic therapy for early breast cancer in women: a clinical practice guideline
A Eisen, G G Fletcher, S Gandhi, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
S Gandhi, G G Fletcher, A Eisen, et al.
Current Oncology (Toronto, Ont.)
|
April 8, 2015
Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline
M Mates, G G Fletcher, O C Freedman, et al.
Current Oncology (Toronto, Ont.)
|
June 10, 2011
Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres
Y Madarnas, S F Dent, S F Husain, et al.
Investigational New Drugs
|
September 28, 2013
NCIC CTG IND.181: phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies
S F Dent, K A Gelmon, K N Chi, et al.
Page
of 2